 Billie Carstens
Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2024 | 292 | 0.380 |
Why?
| | Gene Rearrangement | 2 | 2024 | 151 | 0.300 |
Why?
| | Chromosome Aberrations | 2 | 2024 | 157 | 0.250 |
Why?
| | Lymphoma, B-Cell | 2 | 2020 | 107 | 0.240 |
Why?
| | Immunophenotyping | 2 | 2024 | 321 | 0.230 |
Why?
| | Tetraploidy | 1 | 2024 | 7 | 0.230 |
Why?
| | Klinefelter Syndrome | 1 | 2024 | 62 | 0.210 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 70 | 0.210 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2024 | 141 | 0.190 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2013 | 141 | 0.180 |
Why?
| | Leukemia, B-Cell | 1 | 2020 | 14 | 0.170 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2024 | 620 | 0.140 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 1695 | 0.130 |
Why?
| | Genetic Association Studies | 1 | 2018 | 377 | 0.130 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 32 | 0.120 |
Why?
| | Lymphoma, Large-Cell, Anaplastic | 1 | 2013 | 20 | 0.100 |
Why?
| | Mutation | 1 | 2024 | 3964 | 0.100 |
Why?
| | Karyotyping | 2 | 2024 | 107 | 0.090 |
Why?
| | Genes, Immunoglobulin Light Chain | 1 | 2011 | 5 | 0.090 |
Why?
| | Genes, Immunoglobulin Heavy Chain | 1 | 2011 | 10 | 0.090 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1279 | 0.090 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2013 | 235 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 234 | 0.080 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 2420 | 0.080 |
Why?
| | Translocation, Genetic | 3 | 2015 | 107 | 0.080 |
Why?
| | Karyotype | 1 | 2024 | 18 | 0.060 |
Why?
| | Chromosomes, Human, X | 1 | 2024 | 75 | 0.050 |
Why?
| | Sex Chromosome Aberrations | 1 | 2024 | 67 | 0.050 |
Why?
| | Aneuploidy | 1 | 2024 | 93 | 0.050 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2015 | 319 | 0.050 |
Why?
| | Young Adult | 4 | 2024 | 13243 | 0.050 |
Why?
| | Prognosis | 2 | 2024 | 4031 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2018 | 1185 | 0.050 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 81 | 0.050 |
Why?
| | Retrospective Studies | 3 | 2024 | 15628 | 0.040 |
Why?
| | Child | 4 | 2024 | 22037 | 0.040 |
Why?
| | Cytogenetic Analysis | 1 | 2020 | 34 | 0.040 |
Why?
| | Male | 6 | 2024 | 67718 | 0.040 |
Why?
| | Histocytochemistry | 1 | 2018 | 82 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2011 | 2249 | 0.040 |
Why?
| | Female | 6 | 2024 | 73162 | 0.040 |
Why?
| | Adolescent | 3 | 2024 | 21555 | 0.040 |
Why?
| | Infant | 2 | 2024 | 9467 | 0.030 |
Why?
| | Humans | 8 | 2024 | 137514 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2024 | 10821 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 328 | 0.030 |
Why?
| | Antigens, CD7 | 1 | 2015 | 2 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3205 | 0.030 |
Why?
| | CD13 Antigens | 1 | 2015 | 10 | 0.030 |
Why?
| | Child, Preschool | 2 | 2024 | 11097 | 0.030 |
Why?
| | Gene Amplification | 1 | 2015 | 109 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1132 | 0.030 |
Why?
| | Rabbits | 1 | 2015 | 792 | 0.030 |
Why?
| | Age of Onset | 1 | 2015 | 522 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2024 | 7593 | 0.020 |
Why?
| | Abnormal Karyotype | 1 | 2011 | 3 | 0.020 |
Why?
| | Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2011 | 12 | 0.020 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2013 | 215 | 0.020 |
Why?
| | Adult | 2 | 2024 | 37821 | 0.020 |
Why?
| | DNA, Neoplasm | 1 | 2011 | 165 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2011 | 305 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2013 | 1740 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2011 | 1241 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 1402 | 0.010 |
Why?
| | Aged | 1 | 2024 | 23798 | 0.010 |
Why?
| | Middle Aged | 1 | 2024 | 33355 | 0.010 |
Why?
| | Animals | 1 | 2015 | 37011 | 0.010 |
Why?
|
|
Carstens's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|